Novel bladder catheterization device

Active Project Grant Awarded Last action

Award ID
R43DK139812
Recipient
Awarding agency
Obligated
$1,068,096

Award facts

Completion date 57% complete
Originally
Place of performance
Minneapolis, MN 55414, USA

Award details come from USAspending.gov.

About this award

The National Institute of Diabetes and Digestive and Kidney Diseases awarded Minnesota Healthsolutions Corporation $1,068,096 on September 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and evaluate a prototype novel bladder catheterization device.

The device addresses a critical clinical gap in urologic management. Over one million Americans—including more than 250,000 people with spinal cord injury, 120,000 with spina bifida, and populations living with prostate enlargement, diabetes, multiple sclerosis, and other neurodegenerative diseases—depend on catheters for bladder drainage due to neurogenic bladder. Up to 10 percent of patients in long-term care facilities are catheter-dependent. Current bladder management methods carry significant morbidity and inconvenience; the proposed system incorporates several innovative features designed to create a simpler, more reliable, and safer catheterization approach.

Minnesota Healthsolutions Corporation, a woman-owned small business based in Minneapolis, Minnesota, will perform the work through August 31, 2027. The company specializes in medical device innovation and has previously received federal support from multiple NIH institutes for device development projects including dialysis cannulation needles, safety devices, and digital health interventions.

Description

Abstract
This project relates to the development of a novel catheterization device which will create a new method for bladder drainage. IT is estimated that over one million americans, including tens of thousands of children, have a neurogenic bladder (bladder failure) requiring use of a catheter to drain urine. This includes over 250,000 people with spinal cord injury, 120,000 people living with spina bifida, and a subset of the tens of millions of americans living with prostate enlargement, diabetes, multiple sclerosis and other neurogenerative diseases. Up to 10 percent of patients in long-term care facilities are catheter-dependent. Current bladder management methods are associated with significant morbidity and inconvenience. Developing a simple, reliable, and safe catheterization approach would provide a novel bladder drainage method in a field where meaningful innovation is necessary. The proposed project explores a novel bladder catheterization system with several innovative features. A prototype device will be developed and evaluated.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $356,032
Amendment $356,032
Original award $356,032

Quick answers

Who received award R43DK139812?

R43DK139812 was awarded to Minnesota Healthsolutions Corporation by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 15, 2025.

How much is award R43DK139812 worth?

$1,068,096 has been obligated on R43DK139812.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award